SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
Body, A. L.; Martin, C.; Busija, L.; Lal, L.; Ahern, E. S.; MacIntyre, R. C.; Segelov, E.
Show abstract
COVID-19 disease is associated with higher morbidity and mortality in cancer patients. Our study aimed to characterize the optimal strategy to improve vaccine induced protection against COVID-19 in children and adolescents with cancer. Results from The SerOzNET study will contribute comprehensive data on serology, cellular immune correlates from functional T-cell assays, quality of life data, and associated toxicity in relation to COVID-19 vaccination in children and adults with cancer. In this plan, we describe the statistics that will be used to report results of the SerOzNET study. SerOzNET examines COVID-19 vaccine response in children and adolescents with cancer. We have no conflicts of interest to disclose.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial 94%
- Psychological Impact of the Galleri Test (sIG(n)al): Protocol for a longitudinal evaluation of the psychological impact of receiving a cancer signal in the NHS-Galleri Trial 91%
- CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults 91%
Similar papers in this journal
- Study Protocol: LIAM Mc Trial (Linking In with Advice and supports for Men impacted by Metastatic cancer) 92%
- Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPIC kids ): Study Design and Protocol 91%
- Immune response induced by the Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH) 91%
Similar papers in this journal
Similar papers in this journal
- UKCTOCS Update: Applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis 89%
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 89%
- The Melanoma Genomics Managing Your Risk Study randomised controlled trial: Statistical Analysis Plan 89%
Similar papers in this journal
- Study Protocol of A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localized Rectal Cancer 94%
- ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer 93%
- Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.